Literature DB >> 15574918

Bile-mediated aminoglycoside sensitivity in Lactobacillus species likely results from increased membrane permeability attributable to cholic acid.

Christopher A Elkins1, Lisa B Mullis.   

Abstract

Few studies have been conducted on antimicrobial resistance in lactobacilli, presumably because of their nonpathogenic nature as anaerobic commensals. We assessed resistance in 43 type strains and isolates representing 14 species by using agar disk diffusion and MIC analysis in MRS medium. Most noteworthy were two general phenotypes displayed by nearly every strain tested: (i) they were more susceptible (up to 256-fold in some cases) to the deconjugated bile acid cholic acid than to the conjugate taurocholic or taurodeoxycholic acid, and (ii) they became susceptible to aminoglycosides when assayed on agar medium containing 0.5% fractionated bovine bile (ox gall). Two-dimensional MIC analyses of one representative strain, Lactobacillus plantarum WCFS1, at increasing concentrations of ox gall (0 to 30.3 mg/ml) displayed corresponding decreases in resistance to all of the aminoglycosides tested and ethidium bromide. This effect was clinically relevant, with the gentamicin MIC decreasing from >1,000 to 4 mug/ml in just 3.8 mg of ox gall per ml. In uptake studies at pH 6.5, [G-3H]gentamicin accumulation increased over control levels when cells of this strain were exposed to bile acids or reserpine but not when they were exposed to carbonyl cyanide m-chlorophenylhydrazone. The effect was dramatic, particularly with cholic acid, increasing up to 18-fold, whereas only modest increases, 3- and 5-fold, could be achieved with taurocholic acid and ox gall, respectively. Since L. plantarum, particularly strain WCFS1, is known to encode bile salt hydrolase (deconjugation) activity, our data indicate that mainly cholic acid, but not taurocholic acid, effectively permeabilizes the membrane to aminoglycosides. However, at pHs approaching neutral conditions in the intestinal lumen, aminoglycoside resistance due to membrane impermeability may be complemented by a potential efflux mechanism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15574918      PMCID: PMC535180          DOI: 10.1128/AEM.70.12.7200-7209.2004

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  43 in total

Review 1.  Evaluation of veterinary drug residues in food for their potential to affect human intestinal microflora.

Authors:  C E Cerniglia; S Kotarski
Journal:  Regul Toxicol Pharmacol       Date:  1999-06       Impact factor: 3.271

Review 2.  Bacteriocins: safe, natural antimicrobials for food preservation.

Authors:  J Cleveland; T J Montville; I F Nes; M L Chikindas
Journal:  Int J Food Microbiol       Date:  2001-12-04       Impact factor: 5.277

3.  An ABC-type multidrug transporter of Lactococcus lactis possesses an exceptionally broad substrate specificity.

Authors:  Gerrit J. Poelarends; Piotr Mazurkiewicz; Monique Putman; Robbert H. Cool; Hendrik W. van Veen; Wil N. Konings
Journal:  Drug Resist Updat       Date:  2000-12       Impact factor: 18.500

4.  Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis.

Authors:  Nathan Shankar; Arto S Baghdayan; Michael S Gilmore
Journal:  Nature       Date:  2002-06-13       Impact factor: 49.962

5.  Bacteria recovered from teeth with apical periodontitis after antimicrobial endodontic treatment.

Authors:  L E Chávez De Paz; G Dahlén; A Molander; A Möller; G Bergenholtz
Journal:  Int Endod J       Date:  2003-07       Impact factor: 5.264

Review 6.  Mechanism of bactericidal action of aminoglycosides.

Authors:  B D Davis
Journal:  Microbiol Rev       Date:  1987-09

7.  Genes encoding bile salt hydrolases and conjugated bile salt transporters in Lactobacillus johnsonii 100-100 and other Lactobacillus species.

Authors:  C A Elkins; S A Moser; D C Savage
Journal:  Microbiology       Date:  2001-12       Impact factor: 2.777

8.  Could bacterial vaginosis be due to the competitive suppression of lactobacilli by aerobic microorganisms?

Authors:  B Fredricsson; K Englund; C E Nord; L Weintraub
Journal:  Gynecol Obstet Invest       Date:  1992       Impact factor: 2.031

9.  Analysis of a complete library of putative drug transporter genes in Escherichia coli.

Authors:  K Nishino; A Yamaguchi
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

10.  The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533.

Authors:  R David Pridmore; Bernard Berger; Frank Desiere; David Vilanova; Caroline Barretto; Anne-Cecile Pittet; Marie-Camille Zwahlen; Martine Rouvet; Eric Altermann; Rodolphe Barrangou; Beat Mollet; Annick Mercenier; Todd Klaenhammer; Fabrizio Arigoni; Mark A Schell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

View more
  22 in total

1.  Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin.

Authors:  Randal Eckert; Keith M Brady; E Peter Greenberg; Fengxia Qi; Daniel K Yarbrough; Jian He; Ian McHardy; Maxwell H Anderson; Wenyuan Shi
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

2.  Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.

Authors:  Christopher A Elkins; Lisa B Mullis
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

3.  Role of transporter proteins in bile tolerance of Lactobacillus acidophilus.

Authors:  Erika A Pfeiler; Todd R Klaenhammer
Journal:  Appl Environ Microbiol       Date:  2009-07-24       Impact factor: 4.792

Review 4.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

5.  Preventing dysbiosis of the neonatal mouse intestinal microbiome protects against late-onset sepsis.

Authors:  Jeffrey R Singer; Emily G Blosser; Carlene L Zindl; Daniel J Silberger; Sean Conlan; Vincent A Laufer; Daniel DiToro; Clay Deming; Ranjit Kumar; Casey D Morrow; Julia A Segre; Michael J Gray; David A Randolph; Casey T Weaver
Journal:  Nat Med       Date:  2019-11-07       Impact factor: 53.440

6.  In Vitro Evaluation of the Probiotic and Safety Properties of Bacteriocinogenic and Non-Bacteriocinogenic Lactic Acid Bacteria from the Intestines of Nile Tilapia and Common Carp for Their Use as Probiotics in Aquaculture.

Authors:  Pierre Marie Kaktcham; Jules-Bocamdé Temgoua; François Ngoufack Zambou; Gloria Diaz-Ruiz; Carmen Wacher; María de Lourdes Pérez-Chabela
Journal:  Probiotics Antimicrob Proteins       Date:  2018-03       Impact factor: 4.609

7.  Mammalian steroid hormones are substrates for the major RND- and MFS-type tripartite multidrug efflux pumps of Escherichia coli.

Authors:  Christopher A Elkins; Lisa B Mullis
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

8.  Bile tolerance and its effect on antibiotic susceptibility of probiotic Lactobacillus candidates.

Authors:  Májeková Hyacinta; Kiňová Sepová Hana; Bilková Andrea; Čisárová Barbora
Journal:  Folia Microbiol (Praha)       Date:  2014-11-22       Impact factor: 2.099

9.  Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria.

Authors:  Peter Kurdi; Koji Kawanishi; Kanako Mizutani; Atsushi Yokota
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

10.  Sudan azo dyes and Para Red degradation by prevalent bacteria of the human gastrointestinal tract.

Authors:  Haiyan Xu; Thomas M Heinze; Donald D Paine; Carl E Cerniglia; Huizhong Chen
Journal:  Anaerobe       Date:  2009-07-04       Impact factor: 3.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.